Approval · Notice of Compliance 18896 · 2017
GLN-EZETIMIBE: Notice of Compliance 18896
Issued January 20, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18896
- Date
- January 20, 2017
- Company
- Glenmark Pharmaceuticals Canada Inc.Concord, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- EZETROL (Merck Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLN-EZETIMIBE | 02460750 | Dormant |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB